BGMS
Price
$1.07
Change
+$0.48 (+80.00%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
5.85M
38 days until earnings call
Intraday BUY SELL Signals
PTHS
Price
$25.77
Change
-$2.23 (-7.96%)
Updated
Jul 2 closing price
Capitalization
89.57M
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BGMS vs PTHS

BGMS vs PTHS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BGMS vs. PTHS commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGMS is a Hold and PTHS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2026
Stock price -- (BGMS: $0.60 vs. PTHS: $25.77)
Brand notoriety: BGMS and PTHS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BGMS: 1% vs. PTHS: 118%
Market capitalization -- BGMS: $5.85M vs. PTHS: $89.57M
BGMS [@Biotechnology] is valued at $5.85M. PTHS’s [@Biotechnology] market capitalization is $89.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $134.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BGMS’s FA Score shows that 1 FA rating(s) are green whilePTHS’s FA Score has 0 green FA rating(s).

  • BGMS’s FA Score: 1 green, 4 red.
  • PTHS’s FA Score: 0 green, 5 red.
According to our system of comparison, BGMS is a better buy in the long-term than PTHS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BGMS’s TA Score shows that 3 TA indicator(s) are bullish while PTHS’s TA Score has 4 bullish TA indicator(s).

  • BGMS’s TA Score: 3 bullish, 6 bearish.
  • PTHS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PTHS is a better buy in the short-term than BGMS.

Price Growth

BGMS (@Biotechnology) experienced а -0.17% price change this week, while PTHS (@Biotechnology) price change was -11.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.30%. For the same industry, the average monthly price growth was +5.93%, and the average quarterly price growth was +1921.84%.

Reported Earning Dates

BGMS is expected to report earnings on Aug 12, 2026.

PTHS is expected to report earnings on Aug 24, 2026.

Industries' Descriptions

@Biotechnology (+2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTHS($89.6M) has a higher market cap than BGMS($5.85M). PTHS YTD gains are higher at: -16.871 vs. BGMS (-59.392). BGMS has higher annual earnings (EBITDA): -4.45M vs. PTHS (-49.96M). PTHS has more cash in the bank: 32M vs. BGMS (3.34M). BGMS has less debt than PTHS: BGMS (0) vs PTHS (26.6M). PTHS has higher revenues than BGMS: PTHS (27.7M) vs BGMS (1.53M).
BGMSPTHSBGMS / PTHS
Capitalization5.85M89.6M7%
EBITDA-4.45M-49.96M9%
Gain YTD-59.392-16.871352%
P/E Ratio0.14N/A-
Revenue1.53M27.7M6%
Total Cash3.34M32M10%
Total Debt026.6M-
FUNDAMENTALS RATINGS
BGMS: Fundamental Ratings
BGMS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
34
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BGMSPTHS
RSI
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 25 days ago
86%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
BGMS
Daily Signal:
Gain/Loss:
PTHS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCR45.001.36
+3.12%
Amcor plc
SNOA1.12N/A
N/A
Sonoma Pharmaceuticals Inc
BOTJ24.51N/A
N/A
Bank of the James Financial Group
EIKN11.45N/A
N/A
Eikon Therapeutics
CALY18.26-0.38
-2.04%
Callaway Golf Company

BGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BGMS has been loosely correlated with KAPA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BGMS jumps, then KAPA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGMS
1D Price
Change %
BGMS100%
N/A
KAPA - BGMS
45%
Loosely correlated
+0.54%
MIRM - BGMS
36%
Loosely correlated
N/A
BRNS - BGMS
31%
Poorly correlated
N/A
ORMP - BGMS
30%
Poorly correlated
N/A
PTHS - BGMS
28%
Poorly correlated
-7.96%
More

PTHS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTHS has been loosely correlated with KLRS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PTHS jumps, then KLRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTHS
1D Price
Change %
PTHS100%
-7.96%
KLRS - PTHS
43%
Loosely correlated
N/A
PASG - PTHS
38%
Loosely correlated
N/A
INKT - PTHS
36%
Loosely correlated
N/A
LIXT - PTHS
34%
Loosely correlated
N/A
BGMS - PTHS
28%
Poorly correlated
N/A
More